KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Change in Accured Expenses (2016 - 2025)

Elevance Health (ELV) has disclosed Change in Accured Expenses for 17 consecutive years, with -$2.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 88.25% to -$2.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$720.0 million, a 164.71% decrease, with the full-year FY2025 number at -$720.0 million, down 164.71% from a year prior.
  • Change in Accured Expenses was -$2.3 billion for Q4 2025 at Elevance Health, down from -$151.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.6 billion in Q3 2023 to a low of -$2.3 billion in Q4 2025.
  • A 5-year average of $109.6 million and a median of $203.0 million in 2021 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: crashed 1596.0% in 2021, then surged 4679.41% in 2023.
  • Elevance Health's Change in Accured Expenses stood at -$374.0 million in 2021, then surged by 160.43% to $226.0 million in 2022, then tumbled by 134.07% to -$77.0 million in 2023, then crashed by 1458.44% to -$1.2 billion in 2024, then tumbled by 88.25% to -$2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Change in Accured Expenses are -$2.3 billion (Q4 2025), -$151.0 million (Q3 2025), and $738.0 million (Q2 2025).